TY  - GEN
AU  - Brase,Jan C
AU  - Schmidt,Marcus
AU  - Fischbach,Thomas
AU  - Sültmann,Holger
AU  - Bojar,Hans
AU  - Koelbl,Heinz
AU  - Hellwig,Birte
AU  - Rahnenführer,Jörg
AU  - Hengstler,Jan G
AU  - Gehrmann,Mathias C
TI  - ERBB2 and TOP2A in breast cancer: a comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and prediction
SN  - 1557-3265
PY  - 2010///0812
KW  - Antigens, Neoplasm
KW  - genetics
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Cohort Studies
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - DNA Topoisomerases, Type II
KW  - DNA-Binding Proteins
KW  - Epirubicin
KW  - Female
KW  - Gene Amplification
KW  - Humans
KW  - Immunoenzyme Techniques
KW  - In Situ Hybridization, Fluorescence
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Neoplasm Proteins
KW  - metabolism
KW  - Neoplasm Staging
KW  - Pilot Projects
KW  - Poly-ADP-Ribose Binding Proteins
KW  - RNA, Neoplasm
KW  - Receptor, ErbB-2
KW  - Receptors, Estrogen
KW  - Survival Rate
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-09-2471
ER  -